Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+7.1%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$51.4B
AUM Growth
+$2.6B
(+5.3%)
Cap. Flow
+$799M
Cap. Flow
% of AUM
1.55%
Top 10 Holdings %
Top 10 Hldgs %
11.68%
Holding
2,449
New
226
Increased
917
Reduced
928
Closed
240
Top Buys
| 1 |
US Bancorp
USB
|
+$178M |
| 2 |
Truist Financial
TFC
|
+$132M |
| 3 |
BZUN
Baozun
BZUN
|
+$98.6M |
| 4 |
Crown Castle
CCI
|
+$98.4M |
| 5 |
StepStone Group
STEP
|
+$98.1M |
Top Sells
| 1 |
Alibaba
BABA
|
+$404M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$213M |
| 4 |
JPMorgan Chase
JPM
|
+$167M |
| 5 |
AT&T
T
|
+$133M |
Sector Composition
| 1 | Healthcare | 21.42% |
| 2 | Technology | 20.04% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPRX
1651
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $283K | ﹤0.01% |
7,521
+7,490
| +24,161% | +$282K |
|
|
KDNY
1652
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $282K | ﹤0.01% |
18,099
+16,378
| +952% | +$255K |
|
1653
Willis Towers Watson
WTW
$33.2B
| $279K | ﹤0.01% |
1,221
+735
| +151% | +$168K |
|
1654
Deluxe
DLX
$858M
| $279K | ﹤0.01% |
6,639
+3,866
| +139% | +$162K |
|
1655
PolyPid
PYPD
$54.8M
| $278K | ﹤0.01% |
1,011
| – | – |
|
|
NVRO
1656
DELISTED
NEVRO CORP.
NVRO
| $277K | ﹤0.01% |
1,987
-7,326
| -79% | -$1.02M |
|
1657
Lennar Class B
LEN.B
$33.8B
| $276K | ﹤0.01% |
3,520
+1,164
| +49% | +$91.3K |
|
1658
Fastenal
FAST
$54.3B
| $275K | ﹤0.01% |
10,930
-4,772
| -30% | -$120K |
|
1659
Insight Enterprises
NSIT
$3.96B
| $274K | ﹤0.01% |
2,876
+2,224
| +341% | +$212K |
|
1660
Greif
GEF
$3.54B
| $272K | ﹤0.01% |
4,769
-774
| -14% | -$44.1K |
|
1661
Kite Realty
KRG
$4.97B
| $270K | ﹤0.01% |
14,017
+1,707
| +14% | +$32.9K |
|
|
SOLY
1662
DELISTED
Soliton, Inc.
SOLY
| $268K | ﹤0.01% |
+15,230
| New | +$268K |
|
|
WPF.WS
1663
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
| $267K | ﹤0.01% |
166,666
| – | – |
|
1664
Anavex Life Sciences
AVXL
$762M
| $266K | ﹤0.01% |
+17,774
| New | +$266K |
|
1665
Group 1 Automotive
GPI
$6.09B
| $261K | ﹤0.01% |
1,649
+344
| +26% | +$54.4K |
|
1666
Quest Diagnostics
DGX
$20.5B
| $257K | ﹤0.01% |
2,006
+1,040
| +108% | +$133K |
|
1667
F5
FFIV
$18.8B
| $256K | ﹤0.01% |
1,225
+589
| +93% | +$123K |
|
1668
BioCryst Pharmaceuticals
BCRX
$1.68B
| $253K | ﹤0.01% |
24,914
+24,750
| +15,091% | +$251K |
|
1669
Sierra Bancorp
BSRR
$408M
| $251K | ﹤0.01% |
9,359
+14
| +0.1% | +$375 |
|
1670
Consolidated Edison
ED
$35B
| $251K | ﹤0.01% |
3,362
-7,419
| -69% | -$554K |
|
|
SCVX.WS
1671
DELISTED
SCVX Corp.
SCVX.WS
| $250K | ﹤0.01% |
250,000
| – | – |
|
1672
PACCAR
PCAR
$51.8B
| $246K | ﹤0.01% |
3,972
-449
| -10% | -$27.8K |
|
|
FRLN
1673
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $246K | ﹤0.01% |
1,333
| – | – |
|
1674
NIO
NIO
$13.6B
| $243K | ﹤0.01% |
+6,225
| New | +$243K |
|
1675
Cinemark Holdings
CNK
$3.12B
| $241K | ﹤0.01% |
11,826
-12,953
| -52% | -$264K |
|